124 related articles for article (PubMed ID: 1324317)
21. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
22. Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530.
Dubé D; Blouin M; Brideau C; Chan CC; Desmarais S; Ethier D; Falgueyret JP; Friesen RW; Girard M; Girard Y; Guay J; Riendeau D; Tagari P; Young RN
Bioorg Med Chem Lett; 1998 May; 8(10):1255-60. PubMed ID: 9871745
[TBL] [Abstract][Full Text] [Related]
23. Derivatives of 2-[[N-(Aminocarbonyl)-N-hydroxyamino]methyl]-1,4- benzodioxan as orally active 5-lipoxygenase inhibitors.
Satoh Y; Powers C; Toledo LM; Kowalski TJ; Peters PA; Kimble EF
J Med Chem; 1995 Jan; 38(1):68-75. PubMed ID: 7837242
[TBL] [Abstract][Full Text] [Related]
24. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors.
Spaethe SM; Snyder DW; Pechous PA; Clarke T; VanAlstyne EL
Biochem Pharmacol; 1992 Jan; 43(2):377-82. PubMed ID: 1310855
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor.
Shirumalla RK; Sharma P; Dastidar SG; Paliwal JK; Kakar S; Varshney B; Singh Saini G; Sattigeri V; Salman M; Ray A
Inflamm Res; 2008 Mar; 57(3):135-43. PubMed ID: 18369577
[TBL] [Abstract][Full Text] [Related]
26. Multitarget drugs: synthesis and preliminary pharmacological characterization of zileuton analogues endowed with Dual 5-LO inhibitor and NO-dependent activities.
Boschi D; Giorgis M; Cena C; Talniya NC; Di Stilo A; Morini G; Coruzzi G; Guaita E; Fruttero R; Gasco A
ChemMedChem; 2010 Sep; 5(9):1444-9. PubMed ID: 20645382
[No Abstract] [Full Text] [Related]
27. Characterization of A-93178, an iminoxy-quinoline inhibitor of leukotriene biosynthesis.
Bell RL; Harris RR; Bouska JB; Hulkower KI; Moore J; Bhatia P; Malo PE; Kalosa T; Brooks CD; Carter GW
Adv Exp Med Biol; 1997; 433():91-4. PubMed ID: 9561111
[No Abstract] [Full Text] [Related]
28. The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor.
Bell RL; Bouska J; Young PR; Lanni C; Machinist J; Malo PE; Summers JB; Brooks DW; Carter GW
Agents Actions; 1993 Mar; 38(3-4):178-87. PubMed ID: 8213344
[TBL] [Abstract][Full Text] [Related]
29. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors.
Kolasa T; Brooks CD; Rodriques KE; Summers JB; Dellaria JF; Hulkower KI; Bouska J; Bell RL; Carter GW
J Med Chem; 1997 Feb; 40(5):819-24. PubMed ID: 9057869
[TBL] [Abstract][Full Text] [Related]
30. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of leukotriene formation in human leukocytes by halothane.
Yamaoka A; Sumimoto H; Takeshige K; Itoh T; Isobe R; Yoshitake J; Minakami S
Biochim Biophys Acta; 1987 Apr; 918(3):284-92. PubMed ID: 3032266
[TBL] [Abstract][Full Text] [Related]
32. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
Görlitzer K; Fabian J; Frohberg P; Drutkowski G
Pharmazie; 2002 Apr; 57(4):243-9. PubMed ID: 11998442
[TBL] [Abstract][Full Text] [Related]
33. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.
Ducharme Y; Brideau C; Dubé D; Chan CC; Falgueyret JP; Gillard JW; Guay J; Hutchinson JH; McFarlane CS; Riendeau D
J Med Chem; 1994 Feb; 37(4):512-8. PubMed ID: 8120869
[TBL] [Abstract][Full Text] [Related]
34. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
35. In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase.
Summers JB; Gunn BP; Mazdiyasni H; Goetze AM; Young PR; Bouska JB; Dyer RD; Brooks DW; Carter GW
J Med Chem; 1987 Nov; 30(11):2121-6. PubMed ID: 3669019
[TBL] [Abstract][Full Text] [Related]
36. Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives.
Yatabe T; Kawai Y; Oku T; Tanaka H
Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):966-72. PubMed ID: 9658575
[TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
[TBL] [Abstract][Full Text] [Related]
38. Lipoxygenase inhibitors, Part 6. Synthesis of new tetrahydropyrazine and other heterocyclic compounds by reaction of hydrazonoyl chlorides.
Frohberg P; Wiese M; Nuhn P
Arch Pharm (Weinheim); 1997 Mar; 330(3):47-52. PubMed ID: 9167446
[TBL] [Abstract][Full Text] [Related]
39. 4-acylaminophenol derivatives as novel lipoxygenase inhibitors: synthesis and inhibitory effect on 5-lipoxygenase and leukotriene B4 production.
Kikuchi M; Hashimura Y; Tsuzurahara K; Nagasawa M; Inoue H; Taniguchi T; Uchida T
Biol Pharm Bull; 1994 Aug; 17(8):1038-46. PubMed ID: 7820104
[TBL] [Abstract][Full Text] [Related]
40. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4.
Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R
Biochem Pharmacol; 1994 Jul; 48(1):31-9. PubMed ID: 8043028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]